-
1
-
-
3042956786
-
Kidney transplantation in modified recipients
-
Murray JE, Merrill JP, Dammin GJ et al. Kidney transplantation in modified recipients. Ann Surg 1962 156 : 337 355.
-
(1962)
Ann Surg
, vol.156
, pp. 337-355
-
-
Murray, J.E.1
Merrill, J.P.2
Dammin, G.J.3
-
2
-
-
0345183785
-
The reversal of rejection in human renal homografts with subsequent development of homograft tolerance
-
Starzl TE, Marchioro TL, Waddell WR. The reversal of rejection in human renal homografts with subsequent development of homograft tolerance. Surg Gynecol Obstet 1963 117 : 385 395.
-
(1963)
Surg Gynecol Obstet
, vol.117
, pp. 385-395
-
-
Starzl, T.E.1
Marchioro, T.L.2
Waddell, W.R.3
-
3
-
-
0018756252
-
Cyclosporin A: A preliminary observations in dogs with pancreatic duodenal allografts and patients with cadaveric renal transplants
-
Calne RY, White DJG, Pentlow BD et al. Cyclosporin A: A preliminary observations in dogs with pancreatic duodenal allografts and patients with cadaveric renal transplants. Transplant Proc 1979 11 : 860 864.
-
(1979)
Transplant Proc
, vol.11
, pp. 860-864
-
-
Calne, R.Y.1
White, D.J.G.2
Pentlow, B.D.3
-
4
-
-
0024419167
-
FK 506 for human liver, kidney and pancreas transplantation
-
Starzl TE, Todo S, Fung J et al. FK 506 for human liver, kidney and pancreas transplantation. Lancet 1989 2 : 1000 1004.
-
(1989)
Lancet
, vol.2
, pp. 1000-1004
-
-
Starzl, T.E.1
Todo, S.2
Fung, J.3
-
5
-
-
0014054539
-
The use of heterologous antilymphoid agents in canine renal and liver homotransplantations and in human renal homotransplantations
-
Starzl TE, Marchioro TL, Porter KA et al. The use of heterologous antilymphoid agents in canine renal and liver homotransplantations and in human renal homotransplantations. Surg Gynecol Obstet 1967 124 : 301 318.
-
(1967)
Surg Gynecol Obstet
, vol.124
, pp. 301-318
-
-
Starzl, T.E.1
Marchioro, T.L.2
Porter, K.A.3
-
6
-
-
0342997229
-
The use of antilymphocyte globulin in human renal homotransplantations
-
In. Wolstenholme, G.E.W., O'Connor, M., eds. London: J and A Churchill Limited
-
Starzl TE, Porter KA, Iwasaki Y et al. The use of antilymphocyte globulin in human renal homotransplantations. In Wolstenholme GEW, O'Connor M, eds. Antilymphocytic Serum. London : J and A Churchill Limited, 1967 : 4 34.
-
(1967)
Antilymphocytic Serum.
, pp. 4-34
-
-
Starzl, T.E.1
Porter, K.A.2
Iwasaki, Y.3
-
7
-
-
0014593715
-
Anti-serum to cultured human lymphoblasts: Preparation, purification and immunosuppressive properties in man
-
Najarian JS, Simmons RL, Gewurz H et al. Anti-serum to cultured human lymphoblasts: Preparation, purification and immunosuppressive properties in man. Ann Surg 1969 170 : 617 632.
-
(1969)
Ann Surg
, vol.170
, pp. 617-632
-
-
Najarian, J.S.1
Simmons, R.L.2
Gewurz, H.3
-
8
-
-
0019447825
-
Use of monoclonal antibodies to T-cell subsets for immunological monitoring and treatment in recipients of renal allografts
-
Cosimi AB, Colvin RB, Burton RC et al. Use of monoclonal antibodies to T-cell subsets for immunological monitoring and treatment in recipients of renal allografts. N Engl J Med 1981 305 : 308 314.
-
(1981)
N Engl J Med
, vol.305
, pp. 308-314
-
-
Cosimi, A.B.1
Colvin, R.B.2
Burton, R.C.3
-
9
-
-
0031586439
-
Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients
-
CHIB 201 International Study Group
-
Nashan B, Moore R, Amlot P et al. Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group. Lancet 1997 350 : 1193 1198.
-
(1997)
Lancet
, vol.350
, pp. 1193-1198
-
-
Nashan, B.1
Moore, R.2
Amlot, P.3
-
10
-
-
6844236357
-
Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group
-
Vincenti F, Kirkman R, Light S et al. Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group. N Engl J Med 1998 338 : 161 165.
-
(1998)
N Engl J Med
, vol.338
, pp. 161-165
-
-
Vincenti, F.1
Kirkman, R.2
Light, S.3
-
11
-
-
0024204319
-
Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H
-
Hale G, Dyer MJ, Clark MR et al. Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H. Lancet 1988 2 : 1394 1399.
-
(1988)
Lancet
, vol.2
, pp. 1394-1399
-
-
Hale, G.1
Dyer, M.J.2
Clark, M.R.3
-
12
-
-
0036277088
-
A personal history of the CAMPATH-1H antibody
-
Waldmann H. A personal history of the CAMPATH-1H antibody. Med Oncol 2002 19 (Suppl 3 9.
-
(2002)
Med Oncol
, vol.19
, pp. 3-9
-
-
Waldmann, H.1
-
13
-
-
0032490341
-
Prope tolerance perioperative campath-1H, and low-dose cyclosporine monotherapy in renal allograft recipients
-
Calne RY, Friend PJ, Moffatt S et al. Prope tolerance perioperative campath-1H, and low-dose cyclosporine monotherapy in renal allograft recipients. Lancet 1998 351 : 1701 1702.
-
(1998)
Lancet
, vol.351
, pp. 1701-1702
-
-
Calne, R.Y.1
Friend, P.J.2
Moffatt, S.3
-
14
-
-
0033610681
-
Campath 1H allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipients
-
Calne R, Moffatt SD, Friend PJ et al. Campath 1H allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipients. Transplantation 1999 68 : 1613 1616.
-
(1999)
Transplantation
, vol.68
, pp. 1613-1616
-
-
Calne, R.1
Moffatt, S.D.2
Friend, P.J.3
-
15
-
-
0038638396
-
Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H)
-
Kirk AD, Hale DA, Mannon RB et al. Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H). Transplantation 2003 76 : 120 129.
-
(2003)
Transplantation
, vol.76
, pp. 120-129
-
-
Kirk, A.D.1
Hale, D.A.2
Mannon, R.B.3
-
16
-
-
20544458513
-
Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation-efficacy and safety at five years
-
Watson CJ, Bradley JA, Friend PJ et al. Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation-efficacy and safety at five years. Am J Transplant 2005 5 : 1347 1353.
-
(2005)
Am J Transplant
, vol.5
, pp. 1347-1353
-
-
Watson, C.J.1
Bradley, J.A.2
Friend, P.J.3
-
17
-
-
26644457880
-
Randomized trial of alemtuzumab for prevention of graft rejection and preservation of renal function after kidney transplantation
-
Vathsala A, Ona ET, Tan S-Y et al. Randomized trial of alemtuzumab for prevention of graft rejection and preservation of renal function after kidney transplantation. Transplantation 2005 80 : 765 774.
-
(2005)
Transplantation
, vol.80
, pp. 765-774
-
-
Vathsala, A.1
Ona, E.T.2
Tan, S.-Y.3
-
18
-
-
0038805159
-
Campath-1H induction plus rapamycin monotherapy for renal transplantation: Results of a pilot study
-
Knechtle SJ, Pirsch JD, H Fechner J Jr. et al. Campath-1H induction plus rapamycin monotherapy for renal transplantation: Results of a pilot study. Am J Transplant 2003 3 : 722 730.
-
(2003)
Am J Transplant
, vol.3
, pp. 722-730
-
-
Knechtle, S.J.1
Pirsch, J.D.2
H Fechner Jr., J.3
-
19
-
-
33749444584
-
Outcomes at three years of a prospective pilot study of Campath-1H and sirolimus immunosuppression for renal transplantation
-
Barth RN, Janus CA, Lillesand CA et al. Outcomes at three years of a prospective pilot study of Campath-1H and sirolimus immunosuppression for renal transplantation. Transplant Int 2006 19 : 885 892.
-
(2006)
Transplant Int
, vol.19
, pp. 885-892
-
-
Barth, R.N.1
Janus, C.A.2
Lillesand, C.A.3
-
20
-
-
33644833287
-
Alemtuzumab induction and sirolimus plus mycophenolate mofetil maintenance for CNI and steroid-free kidney transplant immunosuppression
-
Flechner SM, Friend PJ, Brockmann J et al. Alemtuzumab induction and sirolimus plus mycophenolate mofetil maintenance for CNI and steroid-free kidney transplant immunosuppression. Am J Transplant 2005 5 : 3009 3014.
-
(2005)
Am J Transplant
, vol.5
, pp. 3009-3014
-
-
Flechner, S.M.1
Friend, P.J.2
Brockmann, J.3
-
21
-
-
10644270654
-
Living-related donor renal transplantation in HIV+ recipients using alemtuzumab preconditioning and steroid-free tacrolimus monotherapy: A single center preliminary experience
-
Tan HP, Kaczorowski DJ, Basu A et al. Living-related donor renal transplantation in HIV+ recipients using alemtuzumab preconditioning and steroid-free tacrolimus monotherapy: A single center preliminary experience. Transplantation 2004 78 : 1683 1688.
-
(2004)
Transplantation
, vol.78
, pp. 1683-1688
-
-
Tan, H.P.1
Kaczorowski, D.J.2
Basu, A.3
-
22
-
-
29544432261
-
Steroid-free tacrolimus monotherapy following pretransplant thymoglobulin or Campath and laparoscopy in living donor renal transplantation
-
Tan HP, Kaczorowski DJ, Basu A et al. Steroid-free tacrolimus monotherapy following pretransplant thymoglobulin or Campath and laparoscopy in living donor renal transplantation. Transpl Proc 2005 37 : 4235 4240.
-
(2005)
Transpl Proc
, vol.37
, pp. 4235-4240
-
-
Tan, H.P.1
Kaczorowski, D.J.2
Basu, A.3
-
23
-
-
33748477306
-
Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy
-
Tan HP, Kaczorowski DJ, Basu A et al. Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy. Am J Transplant 2006 6 : 2409 2417.
-
(2006)
Am J Transplant
, vol.6
, pp. 2409-2417
-
-
Tan, H.P.1
Kaczorowski, D.J.2
Basu, A.3
-
25
-
-
20144389244
-
Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with thymoglobulin or campath
-
Shapiro R, Basu A, Tan H et al. Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with thymoglobulin or campath. J Am Coll Surg 2005 200 : 505 515.
-
(2005)
J Am Coll Surg
, vol.200
, pp. 505-515
-
-
Shapiro, R.1
Basu, A.2
Tan, H.3
-
26
-
-
33745019088
-
Antilymphoid antibody preconditioning with tacrolimus monotherapy for pediatric renal transplantation
-
Shapiro R, Ellis D, Tan HP et al. Antilymphoid antibody preconditioning with tacrolimus monotherapy for pediatric renal transplantation. J Pediatr 2006 148 : 813 818.
-
(2006)
J Pediatr
, vol.148
, pp. 813-818
-
-
Shapiro, R.1
Ellis, D.2
Tan, H.P.3
-
27
-
-
35748960492
-
Alemtuzumab pre-conditioning with tacrolimus monotherapy in pediatric renal transplantation
-
Shapiro R, Ellis D, Tan HP et al. Alemtuzumab pre-conditioning with tacrolimus monotherapy in pediatric renal transplantation. Am J Transplant 2007 7 : 2736 2738.
-
(2007)
Am J Transplant
, vol.7
, pp. 2736-2738
-
-
Shapiro, R.1
Ellis, D.2
Tan, H.P.3
-
28
-
-
23944434883
-
A randomized trial of three renal transplant induction antibodies: Early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring
-
Ciancio G, Burke GW, Gaynor JJ et al. A randomized trial of three renal transplant induction antibodies: Early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring. Transplantation 2005 80 : 457 465.
-
(2005)
Transplantation
, vol.80
, pp. 457-465
-
-
Ciancio, G.1
Burke, G.W.2
Gaynor, J.J.3
-
29
-
-
33644676984
-
Alemtuzumab induction and prednisone-free maintenance immunotherapy in kidney transplantation: Comparison with basiliximab induction - Long-term results
-
Kaufman DB, Leventhal JR, Axelrod D et al. Alemtuzumab induction and prednisone-free maintenance immunotherapy in kidney transplantation: Comparison with basiliximab induction - Long-term results. Am J Transplant 2005 5 : 2539 2548.
-
(2005)
Am J Transplant
, vol.5
, pp. 2539-2548
-
-
Kaufman, D.B.1
Leventhal, J.R.2
Axelrod, D.3
-
30
-
-
33644882722
-
Alemtuzumab induction and prednisone-free maintenance immunotherapy in simultaneous pancreas-kidney transplantation comparison with rabbit antithymocyte globulin induction - Long-term results
-
Kaufman DB, Leventhal JR, Gallon LG et al. Alemtuzumab induction and prednisone-free maintenance immunotherapy in simultaneous pancreas-kidney transplantation comparison with rabbit antithymocyte globulin induction - Long-term results. Am J Transplant 2006 6 : 331 339.
-
(2006)
Am J Transplant
, vol.6
, pp. 331-339
-
-
Kaufman, D.B.1
Leventhal, J.R.2
Gallon, L.G.3
-
31
-
-
4744354630
-
Campath-1H in renal transplantation: The University of Wisconsin experience
-
Knechtle SJ, Fernandez LA, Pirsch JD et al. Campath-1H in renal transplantation: The University of Wisconsin experience. Surgery 2004 136 : 754 760.
-
(2004)
Surgery
, vol.136
, pp. 754-760
-
-
Knechtle, S.J.1
Fernandez, L.A.2
Pirsch, J.D.3
-
33
-
-
33744906053
-
Alemtuzumab (Campath-1H): A systematic review in organ transplantation
-
Morris PJ, Russell NK. Alemtuzumab (Campath-1H): A systematic review in organ transplantation. Transplantation 2006 81 : 1361 1367.
-
(2006)
Transplantation
, vol.81
, pp. 1361-1367
-
-
Morris, P.J.1
Russell, N.K.2
-
34
-
-
37549043953
-
Alemtuzumab (Campath-1H) in kidney transplantation
-
Ciancio G, Burke GW. Alemtuzumab (Campath-1H) in kidney transplantation. Am J Transplant 2008 8 : 15 20.
-
(2008)
Am J Transplant
, vol.8
, pp. 15-20
-
-
Ciancio, G.1
Burke, G.W.2
-
35
-
-
33847761900
-
Banff '05 meeting report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN')
-
Solez K, Colvin RB, Racusen LC et al. Banff '05 meeting report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 2007 7 : 518 526.
-
(2007)
Am J Transplant
, vol.7
, pp. 518-526
-
-
Solez, K.1
Colvin, R.B.2
Racusen, L.C.3
-
36
-
-
33846222310
-
Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival
-
Terasaki PI, Ozawa M, Castro R. Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival. Am J Transplant 2007 7 : 864 871.
-
(2007)
Am J Transplant
, vol.7
, pp. 864-871
-
-
Terasaki, P.I.1
Ozawa, M.2
Castro, R.3
-
37
-
-
42549117196
-
Alemtuzumab preconditioning with tacrolimus monotherapy-the impact of serial monitoring for donor-specific antibody
-
Shapiro R, Zeevi A, Basu A et al. Alemtuzumab preconditioning with tacrolimus monotherapy-the impact of serial monitoring for donor-specific antibody. Transplantation 2008 85 : 1125 1132.
-
(2008)
Transplantation
, vol.85
, pp. 1125-1132
-
-
Shapiro, R.1
Zeevi, A.2
Basu, A.3
-
38
-
-
33947576549
-
Clinical research, innovative practice and IRB review: Identifying and respecting boundaries
-
Ryan CM, Swanson DP. Clinical research, innovative practice and IRB review: Identifying and respecting boundaries. Am J Transplant 2007 7 : 748 750.
-
(2007)
Am J Transplant
, vol.7
, pp. 748-750
-
-
Ryan, C.M.1
Swanson, D.P.2
-
40
-
-
0001396036
-
Laparoscopic live donor nephrectomy: Evolution of a new standard
-
Tan HP, Maley WR, Kavoussi LR et al. Laparoscopic live donor nephrectomy: Evolution of a new standard. Curr Opin Organ Transplant 2000 12 : 312 318.
-
(2000)
Curr Opin Organ Transplant
, vol.12
, pp. 312-318
-
-
Tan, H.P.1
Maley, W.R.2
Kavoussi, L.R.3
-
41
-
-
0036815187
-
Laparoscopic live donor nephrectomy
-
Tan HP, Orloff M, Marcos A et al. Laparoscopic live donor nephrectomy. Graft 2002 5 : 404 415.
-
(2002)
Graft
, vol.5
, pp. 404-415
-
-
Tan, H.P.1
Orloff, M.2
Marcos, A.3
-
42
-
-
17844363736
-
Reversal of acute cellular rejection after renal transplantation with Campath-1H
-
Basu A, Ramkumar M, Tan HP et al. Reversal of acute cellular rejection after renal transplantation with Campath-1H. Transpl Proc 2005 37 : 923 926.
-
(2005)
Transpl Proc
, vol.37
, pp. 923-926
-
-
Basu, A.1
Ramkumar, M.2
Tan, H.P.3
-
43
-
-
0344666767
-
The natural history of chronic allograft nephropathy
-
Nankivell BJ, Borrows RJ, Fung CLS et al. The natural history of chronic allograft nephropathy. N Engl J Med 2003 349 : 2326 2333.
-
(2003)
N Engl J Med
, vol.349
, pp. 2326-2333
-
-
Nankivell, B.J.1
Borrows, R.J.2
Fung, C.L.S.3
-
44
-
-
34247580226
-
Outcome of alemtuzumab pre-conditioning and tacrolimus monotherapy in living donor liver and kidney transplantation
-
Tan HP, Shapiro R, Tom K et al. Outcome of alemtuzumab pre-conditioning and tacrolimus monotherapy in living donor liver and kidney transplantation. Expert Rev Pharmacoeconomics Outcomes Res 2007 7 : 1 6.
-
(2007)
Expert Rev Pharmacoeconomics Outcomes Res
, vol.7
, pp. 1-6
-
-
Tan, H.P.1
Shapiro, R.2
Tom, K.3
-
45
-
-
0035754206
-
Transplantation tolerance from a historical perspective
-
Starzl TE, Zinkernagel R. Transplantation tolerance from a historical perspective. Nat Rev Immunol 2001 1 : 233 239.
-
(2001)
Nat Rev Immunol
, vol.1
, pp. 233-239
-
-
Starzl, T.E.1
Zinkernagel, R.2
-
46
-
-
0038298787
-
Tolerogenic immunosuppression for organ transplantation
-
Starzl TE, Murase N, Abu-Elmagd K et al. Tolerogenic immunosuppression for organ transplantation. Lancet 2003 361 : 1502 1510.
-
(2003)
Lancet
, vol.361
, pp. 1502-1510
-
-
Starzl, T.E.1
Murase, N.2
Abu-Elmagd, K.3
-
47
-
-
10744225978
-
Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning
-
Shapiro R, Jordan ML, Basu A et al. Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning. Ann Surg 2003 238 : 520 525.
-
(2003)
Ann Surg
, vol.238
, pp. 520-525
-
-
Shapiro, R.1
Jordan, M.L.2
Basu, A.3
-
48
-
-
6344256213
-
Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: With particular reference to hepatitis C virus
-
Marcos A, Eghtesad B, Fung JJ et al. Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: With particular reference to hepatitis C virus. Transplantation 2004 78 : 966 971.
-
(2004)
Transplantation
, vol.78
, pp. 966-971
-
-
Marcos, A.1
Eghtesad, B.2
Fung, J.J.3
-
49
-
-
23044511810
-
Early outcomes in human lung transplantation with Thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy
-
McCurry K, Iacano A, Zeevi A et al. Early outcomes in human lung transplantation with Thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy. J Thorac Cardiovasc Surg 2005 130 : 528 537.
-
(2005)
J Thorac Cardiovasc Surg
, vol.130
, pp. 528-537
-
-
McCurry, K.1
Iacano, A.2
Zeevi, A.3
-
50
-
-
32144464556
-
Intestinal transplantation for short gut syndrome and gut failure: Rewarding outcomes and current consensus
-
Abu-Elmagd K. Intestinal transplantation for short gut syndrome and gut failure: Rewarding outcomes and current consensus. Gastroenterology 2006 130 : 132 137.
-
(2006)
Gastroenterology
, vol.130
, pp. 132-137
-
-
Abu-Elmagd, K.1
-
51
-
-
33845923314
-
Alemtuzumab induction and tacrolimus monotherapy in pancreas transplantation: One- and two-year outcomes
-
Thai NL, Khan A, Tom K et al. Alemtuzumab induction and tacrolimus monotherapy in pancreas transplantation: One- and two-year outcomes. Transplantation 2006 82 : 1621 1624.
-
(2006)
Transplantation
, vol.82
, pp. 1621-1624
-
-
Thai, N.L.1
Khan, A.2
Tom, K.3
-
52
-
-
20044380331
-
Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion
-
Pearl JP, Parris J, Hale DA et al. Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion. Am J Transplant 2005 5 : 465 474.
-
(2005)
Am J Transplant
, vol.5
, pp. 465-474
-
-
Pearl, J.P.1
Parris, J.2
Hale, D.A.3
-
53
-
-
31044451821
-
T-lymphocyte alloresponses of Campath-1H-treated kidney transplant patients
-
Bloom DD, Hu H, Fechner JH et al. T-lymphocyte alloresponses of Campath-1H-treated kidney transplant patients. Transplantation 2006 81 : 81 87.
-
(2006)
Transplantation
, vol.81
, pp. 81-87
-
-
Bloom, D.D.1
Hu, H.2
Fechner, J.H.3
-
54
-
-
1942454828
-
Present experience with Campath-1H in organ transplantation and its potential use in pediatric recipients
-
Knechtle SJ. Present experience with Campath-1H in organ transplantation and its potential use in pediatric recipients. Pediatr Transplant 2004 8 : 106 112.
-
(2004)
Pediatr Transplant
, vol.8
, pp. 106-112
-
-
Knechtle, S.J.1
-
55
-
-
28544440832
-
The evolving role of alemtuzumab in management of patients with CLL
-
Faderl S, Coutre S, Byrd JC et al. The evolving role of alemtuzumab in management of patients with CLL. Leukemia 2005 19 : 2147 2152.
-
(2005)
Leukemia
, vol.19
, pp. 2147-2152
-
-
Faderl, S.1
Coutre, S.2
Byrd, J.C.3
-
56
-
-
27744481221
-
Results from a human renal allograft tolerance trial evaluating T-cell depletion with alemtuzumab combined with deoxyspergualin
-
Kirk AD, Mannon RB, Kleiner DE et al. Results from a human renal allograft tolerance trial evaluating T-cell depletion with alemtuzumab combined with deoxyspergualin. Transplantation 2005 80 : 1051 1059.
-
(2005)
Transplantation
, vol.80
, pp. 1051-1059
-
-
Kirk, A.D.1
Mannon, R.B.2
Kleiner, D.E.3
-
57
-
-
58849117320
-
-
U.S. Scientific Registry of Transplant Recipients Annual Report 2006. From: Accessed January 10th, 2008.
-
U.S. Scientific Registry of Transplant Recipients Annual Report 2006. From : http://www.ustransplant.org. Accessed January 10th, 2008.
-
-
-
-
58
-
-
0037148938
-
Strategies to improve long-term outcomes after renal transplantation
-
Pascual M, Theruvath T, Kawai T et al. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 2002 346 : 580 590.
-
(2002)
N Engl J Med
, vol.346
, pp. 580-590
-
-
Pascual, M.1
Theruvath, T.2
Kawai, T.3
-
59
-
-
0033780696
-
Recommendations for the outpatient surveillance of renal transplant recipients
-
Kasiske BL, Vazquez MA, Harmon WE et al. Recommendations for the outpatient surveillance of renal transplant recipients. Am Soc Transplant J Am Soc Nephrol 2000 11 (Suppl 15 S1 S86.
-
(2000)
Am Soc Transplant J Am Soc Nephrol
, vol.11
, Issue.15
-
-
Kasiske, B.L.1
Vazquez, M.A.2
Harmon, W.E.3
-
60
-
-
26444609695
-
Severe early acute humoral rejection resulting in allograft loss in a renal transplant recipient with Campath-1H induction therapy
-
Hill P, Gagliardini E, Ruggenenti P, Remuzzi G. Severe early acute humoral rejection resulting in allograft loss in a renal transplant recipient with Campath-1H induction therapy. Nephrol Dial Transplant 2005 20 : 1741 1744.
-
(2005)
Nephrol Dial Transplant
, vol.20
, pp. 1741-1744
-
-
Hill, P.1
Gagliardini, E.2
Ruggenenti, P.3
Remuzzi, G.4
|